Dr. Rob Murphy is Professor of Medicine and Biomedical Engineering at Northwestern University where he is Executive Director, Institute for Global Health and John P. Phair Professor of Infectious Diseases. Dr. Murphy’s primary research and clinical interest is viral infections. His original research focused on drug development of new antiviral drugs and vaccines for HIV and viral hepatitis both in the United States and sub-Saharan Africa. During the West African Ebola outbreak, he was the scientific director of the laboratory at the University of Bamako in Mali where confirmatory molecular testing for Ebola was performed. He leads several NIH-supported cooperative agreements including one studying the epigenomics of HIV-related cancers in Nigeria and another developing point-of-care devices and assays that can be used to treat, monitor or prevent HIV-associated conditions in Africa. This project recently pivoted its research focus to developing innovative diagnostic assays and devices for SARS-CoV-2 in a $1.5 billion NIH program referred to as RADx - the Rapid Acceleration of Diagnostics for Coronavirus-19; he sits on the RADx Steering Panel and Clinical Review Board. In December 2020, he co-founded Northwestern CoVAXCEN, the Covid-19 Vaccine Communication & Evaluation Network whose mission is to communicate the most recent data on covid-19 vaccines and therapies. Dr. Murphy has published over 350 scientific papers and book chapters, launched the Global Health Innovation journal and the Biomedical Engineering for Africatextbook; he is Senior Editor-Virology for the British Society for Antimicrobial Chemotherapy Journal of Antimicrobial Chemotherapy and is faculty director for the Northwestern Master’s of Science in Global Health. For the past year, Dr. Murphy has been featured every weekday morning on WGN-TV reporting important scientific updates and answering viewer questions on covid-19.
Stephen Weber is the Chief Medical Officer and Senior Vice President for Clinical Excellence at the University of Chicago Medicine. In this capacity he oversees clinical quality, patient safety and value-based care for the academic health system. Dr. Weber previously served as Chief Healthcare Epidemiologist and Medical Director of Infection Control at the University of Chicago. A Professor of Medicine in the Section of Infectious Diseases and Global Health, he continues to see patients in both the inpatient and ambulatory settings.
Dr. Weber has helped to lead clinical care for the COVID-19 pandemic at the University of Chicago through the health system’s incident command structure. He has also worked closely with the CDC, departments of health and other government officials as well as community and industry leaders to coordinate the regional response and promote policies to ensure access to care and testing throughout Chicago and especially on the city’s South Side.